NOTE: We are upgrading our eBook operations; please allow up to 1-2 days for delivery of your eBook order.
»
Treatment of Leukemia and Lymphoma
 
 

Treatment of Leukemia and Lymphoma, 1st Edition

 
Treatment of Leukemia and Lymphoma, 1st Edition,David Scheinberg,Joseph Jurcic,ISBN9780080490403
 
 
 

  &      

Academic Press

9780080490403

384

Respected serial that features cutting-edge reviews with an emphasis on the molecular bases of drug action, both applied and experimental

eBook
eBook Overview

DRM Free included formats: PDF

USD 260.00
Add to Cart
 
 

Key Features

* Provides an up-to-date, state of the art discussion of a rapidly changing field
* Great breadth covering conventional chemotherapeutic agents, biologic agents such as antibodies, novel small molecule inhibitors and genetically engineered cells
* Written by international experts in each of the fields

Description

New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology.

Detailed descriptions of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well as an understanding of their mechanisms of action and their integration into current therapy are provided. A number of experimental drug reagents currently in clinical investigation are also discussed. The therapies include conventional anti-metabolites, monoclonal antibodies directed to cell surface receptors, antibodies tagged with toxins and radiopharmaceuticals, inhibitors of specific kinases, stem cell transplants, and engineered T-cells designed to selectively target hematopoietic cancers.

The contents of the book will allow practitioners and investigators alike to understand what is current and state of the art as well as what to look for in the future.

Readership

Oncologists, hematologists, cancer researchers, pharmacologists, pharmaceutical and biotechonology company employees

David Scheinberg

Affiliations and Expertise

Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.

Joseph Jurcic

Affiliations and Expertise

Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.

Treatment of Leukemia and Lymphoma, 1st Edition

Kinase Inhibitors in Leukemia
State of the Art Treatment of APL
Investigational Agents in Myeloid Disorders
Methodologic Issues in Investigation of Targeted Therapies in AML
Purine Analogues in Leukemia
Monoclonal Antibody Therapy in Lymphoid Leukemias
Native Antibody and Antibody-Targeted Chemotherapy for Acute Myeloid Leukemia
Radioimmunotherapy of Leukemia
Immunotoxins and Toxin Constructs in Leukemia/Lymphoma
Antibody Therapy of Lymphoma
Vaccines in Leukemia
Therapeutic Idiotype Vaccines for Non-Hodgkin’s Lymphoma
Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma
Donor Lymphocyte Infusions
Somatic Cell Engineering and the Immunotherapy of Leukemias and Lymphomas
 
 
Discount on Science and Technology eBooks | Use code DRMFREE
NOTE: We are upgrading our eBook operations; please allow up to 1-2 days for delivery of your eBook order.